ARGX-213
- Generic Name
- ARGX-213
A Study to Assess the Safety of ARGX-213 in Healthy Volunteers
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- argenx
- Target Recruit Count
- 72
- Registration Number
- NCT06968338
- Locations
- 🇨🇦
Altasciences, Montréal, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath